Kitade Y, Hirota K, Maki Y
Laboratory of Medicinal Chemistry, Gifu Pharmaceutical University, Mitahora-higashi, Japan.
Nucleic Acids Symp Ser. 1992(27):107-8.
Reaction of purine nucleosides, such as 2',3'-isopropylideneinosine (1a) and 2',3'-isopropylideneadenosine (1c), with diisobutylaluminum hydride (DIBAL) in dry tetrahydrofurane resulted in the formation of the corresponding 9-(2',3'-isopropylideneribity)purines (2) in good yields. Oxidation of the ribityl derivatives (2) with NalO4 and subsequent reduction with NaBH4 gave the corresponding 9-(2',3',4'-trihydroxybutyl)-purine derivatives (4) in high yields. Deprotection of compounds 2 and 4 in 80% acetic acid gave the corresponding 9-(2',3',4'-trihydroxybutyl)purines (5) and 9-ribitylpurines (6), respectively.
嘌呤核苷(如2',3'-异亚丙基肌苷(1a)和2',3'-异亚丙基腺苷(1c))与二异丁基氢化铝(DIBAL)在干燥的四氢呋喃中反应,以良好的产率生成相应的9-(2',3'-异亚丙基核糖基)嘌呤(2)。用高碘酸钠氧化核糖基衍生物(2),随后用硼氢化钠还原,以高产率得到相应的9-(2',3',4'-三羟基丁基)嘌呤衍生物(4)。在80%的乙酸中对化合物2和4进行脱保护,分别得到相应的9-(2',3',4'-三羟基丁基)嘌呤(5)和9-核糖基嘌呤(6)。